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Introduction
• Inflammatory Breast Cancer carries a poor prognosis, and 
adequate data has not demonstrated the benefits of potential 
preoperative radiation after inadequate response to 
chemotherapy in terms of a favorable prognosis. 
• The success of mastectomy for treatment of inflammatory 
breast cancer is related to the degree of resectability achieved 
prior to surgery.
• Preoperative radiation can potentially provide another means 
of reduction in cancer mass for patients with a poor response 




– How does preoperative radiation impact the resectability
of tumors, prognosis following resection, and quality of life 
for patients presenting with inflammatory breast cancer 
who were unresponsive to preoperative taxane-based 
chemotherapy? 
• Hypothesis
– The hypothesis is that preoperative radiotherapy is 
effective in converting unresectable inflammatory breast 
cancer to mastectomy after inadequate response to 
taxane-based chemotherapies. 
Approach & Results
• Study design 
– A retrospective medical chart review of 148 IBC patients 
presenting between 2000-2019 was performed. These patients 
were evaluated by breast surgeons after neoadjuvant 
chemotherapy, 16 of whom were not deemed appropriate for 
resection at completion of TBC and referred for preoperative RT. 
– Patient, disease, and pre-surgical treatment characteristics were 
collected using past medical records. 
– Descriptive statistical analysis of surgical outcomes with 
attention to conversion to resectability, surgical margins, 
treatment response, complication rates, on loco-regional 
recurrence were evaluated.
Approach & Results
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Approach & Results
Resectable Partially Resectable
Preop RT 14 (10.47) [1.19] 2 (5.53) [2.25]
No Preop RT 22 (25.53) [0.49] 17 (13.47) [0.92]
X2 (1, N = 55) = 4.8, p = .0028
ypN0T0 Not ypN0T0
Preop RT 4 (2.33) [1.20] 12 (13.67) [0.20]
No Preop RT 4 (5.67) [0.49] 35 (33.33) [0.08]
X2 (1, N = 55) = 2.0, p = .1590
Conclusions
• 88% of patients who underwent preoperative RT 
were converted to resectable
• Resectable patients were able to undergo R0 
resection without significant postoperative 
complications
• High rates of locoregional control were shown
• Patients who show suboptimal response to 
neoadjuvant taxane-based chemotherapy should be 
considered for preoperative RT
Future Directions
• Examine preoperative radiotherapy and its 
potential toxicities in comparison to taxane-
based chemotherapies
• Look at outcomes for patients with attention 
to socioeconomic status 
• Identify more patients for further comparison
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